Skip to content
Review

Advances in peptide-based nanostrategies against drug-resistant bacteria: Natural amino acids to molecular modifications.

Aug 2026 · Biotechnology Advances · pp. 109020 · 0 citations · 168 references
Medicine

TL;DR

This review provides a comprehensive overview of the recent advancements in the innovative design of self-assembled nano AMPs and their therapeutic effects in vivo, and categorizes design strategies based on intermolecular forces between amino acids, including hydrophobic interactions, hydrogen bonding, π-π stacking, and cation-anion-π interactions.

Abstract

In recent years, self-assembled antimicrobial peptides (AMPs) have shown promise in biomedical applications due to their multifunctional properties and high therapeutic potential. This stable nanostructure significantly addresses the clinical limitations associated with peptides, such as protease degradation, limited in vivo efficacy, and short half-life during systemic or oral administration. In this review, we provide a comprehensive overview of the recent advancements in the innovative design of self-assembled nano AMPs and their therapeutic effects in vivo. We categorize design strategies for nanopeptides based on intermolecular forces between amino acids, including hydrophobic interactions, hydrogen bonding, π-π stacking, and cation-anion-π interactions. Additionally, we discuss novel chemical modifications, including hydrophobic modification of peptide chains, glycosylation, and amphiphilic polymerization. Finally, we explore the potential applications of nanopeptides in drug delivery. We hope to provide guidance on promising directions in the field, stimulate broad scientific interest and provide new, effective and selective solutions to the limitations of self-assembled AMPs in clinical applications.

View source

Similar papers

Review Open access Aug 2026

Advances in Peptide-Based Therapeutics: Formulation Strategies and Targeted Drug Delivery Systems

This review presents a unified innovation framework that integrates upstream molecular engineering strategies including cyclization, peptide stapling, D- and β-amino acid substitution, PEGylation, and backbone modification with downstream advanced delivery platforms such as nanocarriers, microneedles, self-assembling h...

Pradip Karale, Saloni Borse, Anjali Gavit et al. · 0 citations
Review Sep 2026

Computational Platforms for Membrane-Active Peptide Therapeutic Design

A broad overview of tools for in silico MAP design, prediction of functional structural ensembles and physicochemical properties, structure–function relationships, drug-target interactions, and formulation strategies for in vivo delivery is provided.

Bing Zan, Charles H. Chen, Mehwish Sabha et al. · 0 citations
Review Open access Aug 2026

Emerging Technologies for Oral Peptide Delivery: From Bioinspired Systems to Smart Device-Assisted Drug Delivery

The analysis identified the main barriers responsible for low oral bioavailability of peptide drugs, as well as promising approaches to overcoming these obstacles, including peptide modification, enzyme inhibition, permeation enhancement, mucolytic strategies, and advanced carrier systems.

Sara Vasović, Lucija V. Vasović, Nikola Martić et al. · 0 citations
Review Open access Sep 2026

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development.

This review highlights recent clinical advances-including motixafortide and zilucoplan-and examines how UAAs are deployed to optimize drug-like characteristics across diverse therapeutic areas, and discusses emerging strategies, illustrative case studies, and design principles that collectively support the development...

Krishna K. Sharma, K. Sharma, Anku Sharma et al. · 0 citations
#protein folding Open access Sep 2026

Harnessing the Folding of Antitumor Peptides for Controlled Carrier-Free Drug Delivery.

An antitumor peptide-based delivery platform in which both termini of a stapled p53 α-helix are linked via a disulfide bond, thereby repurposing nonpolar residues originally involved in target protein (hDM2) binding as a hydrophobic block that drives co-assembly with doxorubicin.

Jae Yun Lee, Moo Chang Park, Sung-Chan Choi et al. · 0 citations
Review Oct 2026

Biomedical Applications of Antimicrobial Peptides: Multifunctional Mechanisms, Engineering Strategies, and Therapeutic Development.

Antimicrobial peptides (AMPs) are small, multifunctional molecules generated by the innate immune systems of various organisms. AMPs possess broad-spectrum antimicrobial activity and operate through mechanisms that target microbial membranes, cell walls, and intracellular processes. These peptides are viewed as promisi...

Xin-Yi Zhang, Jun-Yi Deng, Ya-Nan Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.